Latest Advanced Prostate Cancer News

//Latest Advanced Prostate Cancer News

Urologists Fail to Complete Psycho-Social and Sexual Histories of Prostate Cancer Patients

Malecare and the University of Minnesota collaborated on the first study to investigate what gay and bisexual men are offered and what they try as rehabilitation to address the sexual and urinary effects of prostate cancer [...]

By | April 26th, 2017|Categories: Advanced Prostate Cancer, Gay, Newly Diagnosed|0 Comments

Biopsy Slides Can Now Be Digitalized and Reviewed by Pathologists

The first whole slide imaging (WSI) system that allows for review and interpretation of digital prostate cancer pathology slides prepared from biopsied tissue has been approved by the U.S. Food and Drug Administration (FDA). Malecare is [...]

By | April 25th, 2017|Categories: Advanced Prostate Cancer|0 Comments

Blood Test Determines Effectiveness of Zytiga and or Xtandi, Before You Begin Treatment.

Adna is a new blood test that will tell you if Zytiga and Xtandi will or will not treat castration resistant prostate cancer. Imagine knowing if Zytiga and or Xtandi will fail to help you, [...]

By | April 21st, 2017|Categories: Advanced Prostate Cancer|1 Comment

HSD3B1 gene makes Androgen Deprivation Therapy (ADT) less effective

An inherited genetic change, HSD3B1 gene causes Androgen Deprivation Therapy (ADT) to be less effective for treating metastatic prostate cancer. Physician-researcher Nima Sharifi, M.D. published this finding in the October, 2016 The Lancet Oncology.  While Androgen Deprivation Therapy is effective for many [...]

By | April 20th, 2017|Categories: Advanced Prostate Cancer|0 Comments

A New Steroid for Treating Advanced Prostate Cancer

E4 is a steroid that may become a treatment for advanced prostate cancer, both alone and fin combination with hormone therapy. Ellen Dutman, MSc, a clinical researcher, studied E4 as a treatment to lower testosterone. [...]

By | April 18th, 2017|Categories: Advanced Prostate Cancer|0 Comments

Androgen Deprivation and Dementia “Might” be Linked

Androgen deprivation therapy (ADT, or, “hormone therapy”) may be linked to increased risk of having dementia. Researchers, Nead, Sinha and Nguyen reviewed nine studies by other researchers. Seven of those studies reported an adjusted effect [...]

By | April 17th, 2017|Categories: Advanced Prostate Cancer|0 Comments